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Preprocedure Warfarinization and Brachial Approach for 
Elective Coronary Stent Placement-A Possible Strategy 
to Decrease Cost and Duration of Hospitalization 
Uri Rosenschein, MD, and Stephen G. Ellis, MD 
intracoronary stentlng, while potentially beneficial to treat abrupt closure and to prevent 
restenosis after angioplasty, requires intermediate-term warfarinization to prevent stent 
thrombosis. Hospitalization is often prolonged because of the need to establish antico- 
agulation. Hospital charges have been reported to be considerably higher wlth stenting 
than with balloon angiopiasty alone, although the long-term cost ramifications remain 
uncertain due to the fact that stenting may limit restenosis. We describe a technique 
wherein stent placement is performed while the patient is already partially anticoagu- 
lated, which may decrease costs associated with stenting. 
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INRODUCTION 
Dotter introduced the concept of maintaining vascular 
patency by endovascular stenting in 1969 [ 11. Inadequate 
design of early prototypes was responsible for the delay 
in the clinical application of intracoronary stents. Recent 
improvements in design concurrent with increased need 
for devices that could maintain vessel patency in the 
event of abrupt closure and could offer possible solution 
to restenosis after balloon angioplasty have led to exten- 
sive clinical evaluation of coronary stents. The thrombo- 
genic nature of currently available stents led to complex 
and aggressive anticoagulation protocols [2,3]. The need 
for aggressive anticoagulation has been, in large part, 
responsible for reported rates of bleeding requiring trans- 
fusion or vascular repair of 9-18% [3-51 and prolonged 
hospitalization and increased cost compared to patients 
treated with angioplasty alone [6]. 
In this case report we describe a novel approach to 
stent placement using the brachial approach in a patient 
who had elective ambulatory anticoagulation with war- 
farin for 4 days prior to admission for the procedure. The 
aim of this approach was to attempt to decrease the com- 
plication rate and duration of hospital stay in patients 
requiring elective stent implantation. 
CASE REPORT 
A 60-year-old male with history of coronary artery 
disease for the last 10 years presented with class IV 
angina. In 1981 the patient underwent angioplasty of a 
right coronary (RCA) stenosis. After the angioplasty the 
patient was asymptomatic until December 1990, when he 
began to notice angina on effort. 
Cardiac catheterization revealed 80% stenosis of the 
RCA. The patient underwent successful angioplasty of 
the RCA and was asymptomatic for 4 months when he 
developed angina on effort. Cardiac catheterization re- 
vealed total occulusion of the RCA at the site of the 
previous angioplasty. The patient had temporary relief of 
his symptoms for 2 weeks with increased medical ther- 
apy and then started to suffer from angina on effort. His 
anginal syndrome accelerated in the following 4 weeks to 
having chest pain on minimal effort and occasionally at 
night. His sublingual nitroglycerin consumption has ac- 
celerated to about 6 per day. The patient was then re- 
ferred to the University of Michigan Medical Center for 
stent placement. 
Risk factors for coronary artery disease include hyper- 
cholesterolemia and a history of cigarette smoking. Med- 
ications included aspirin (325 mg daily), dipyridamole 
(75 mg every 8 hours), nitroglycerin (6.5 mg every 8 
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hours), nifedipine (60 mg once daily), and sublingual 
nitroglycerin (0.4 mg average of about 6 times a day). 
The patient was treated with warfarin (5 mg daily) 4 days 
prior to his admission. Two hours prior to the procedure, 
an intravenous dextran drip (100 ml/hr) was started. 
Physical examination was unremarkable. His laboratory 
studies were notable for a prothrombin time of 13.2 sec 
(PT ratio of 1.1) and a hemoglobin of 14.9 g/dl. 
A right brachial artery cutdown was performed with the 
help of electrocauterization to prevent excessive bleeding. 
A 9F vascular sheath was introduced to the right brachial 
artery and flushed with heparin (5000 U). Cardiac cath- 
eterization revealed 85% stenosis of the mid RCA (Fig. 
1). A heparin bolus (12,000 U) was given and an intra- 
venous drip (lo00 U/hr) was started. Using a 9 F “Hockey 
Stock” guiding catheter (Sherpa@’, Medtronic, Minne- 
apolis, MN), a 2.5 mm balloon catheter (P-14@, Scimed, 
Maple Grove, MN), and a 0.014 in. exchange-length 
guidewire (HighTorque Floppy@, Advanced Cardiovas- 
cular Systems, Temecula, CA), successful predilation of 
the RCA stenosis was performed with a maximal pressure 
of 8 atm for 90 sec. Then, a 3.0 mm intracoronary stent 
system (Palmaz-Schatz Stent@’, Johnson and Johnson In- 
terventional Systems, Warren, NJ) was exchanged with 
the balloon angioplasty system and successfully placed in 
the predilated region. Contrast material injections through 
the guiding catheter and the stent’s delivery sheath helped 
to identify the predilated zone (Fig. 2). After the stent 
placement there was 19% residual stenosis (measured by 
electronic calipers), no angiographic signs of thrombus, 
and a TIMI 3 flow. Due to the residual stenosis the stent 
system was exchanged with a 3.25 mm balloon system 
system (Piccollinom, Schneider, Minneapolis, MN). The 
balloon was inflated inside the stent for a maximal pres- 
sure of 10 atm for 90 sec. The final result documented 8% 
residual stenosis with no angiographic signs of thrombus 
and a TIMI 3 flow (Fig. 3). Arterial repair and cutdown 
closure were performed in a standard fashion. Bleeding at 
the incision site was easily controllable, but somewhat 
more than usual. 
After the procedure the patient was admitted to the 
hospital. His hospital course was uneventful. The patient 
was ambulatory 9 hr after the procedure. His cut-down 
area exhibited mild swelling and ecchymosis without 
motor or sensory deficits, and there was no need for 
blood transfusion. The day after the procedure the pro- 
thrombin time was 14.7 sec (PT ratio of 1.3) and heparin 
Fig. 1. Sequential angiograms of the right coronary artery 
stenting in the left anterior oblique projection. A: Baseline an- 
giogram showing 85% stenosis of the mid RCA. B: Stent posi- 
tioned at the stenosis site. There Is miid opaclflcation of the 
distal RCA after contrast injection through the stent‘s sheath. 
C: Final result shows 8% residual stenosis, with no thrombosis 
and with TIMI 3 flow. 
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was tapered gradually over 12 hrs. The patient was dis- 
charged 2 days after the stent placement with FT of 16.8 
sec and hemoglobin of 13.0 g/dl. At follow-up 3 months 
after the procedure, the patient was asymptomatic with- 
out limitations in his physical activity and with no need 
for sublingual nitroglycerin. 
DISCUSSION 
Since the original description of Dotter’s tubular coil 
spring, many variants of the original concept have been 
introduced. While different in geometry, composition, 
and mechanical behavior, all the currently investigated 
stents share thrombogenic properties. The stents’ throm- 
bogenicity stems in part from the positive electric charge 
in these metallic devices. Local injury and disruption of 
laminar flow due to irregular intimal tears contribute to 
the local thrombogenicity [7,8]. Initial experience with 
the Palmaz Schatz StenP,  which was no more throm- 
bogenic than other stents in animal studies, found a 16% 
subacute thrombotic closure incidence when patients 
were treated with aspirin, dipyridamole, dextran, and 
heparin, but without warfarin [3]. The addition of war- 
farin for 1-3 months has decreased this rate to 3% [3]. 
A recent case-control study found that the patient 
charges for stent placement were considerably higher 
($13,274 & 7,366 vs. $5,450 * 1,240) and the duration 
of hospitalization was longer (5.3 k 2.7 days vs. 1.3 2 
0.6 days) than routine balloon angioplasty [6]. The 
longer in-hospital stay was primarily attributed to the 
time required for conversion of patients from intravenous 
heparin to adequate and stable oral anticoagulation status 
with warfarin. The higher morbidity in the stent patients 
was due to femoral artery bleeding, hematoma forma- 
tion, and vascular repair. This tendency to a higher ac- 
cess-site complication rate is probably a result of the 
femoral approach used for stent placement, which in- 
volves blind puncture of the artery and a need to remove 
the large-size (usually 8 F, but 9 F for larger coronary 
stents of some types) vascular sheaths at a time. when 
vigorous anticoagulation is required. 
This case illustrates a novel approach to overcome the 
limitations of the current methods of stent placement. 
The patient was treated electively with warfarin prior to 
the stent placement. Thus, the need for long hospitaliza- 
tion during the conversion from intravenous heparin to 
oral anticoagulation with warfarin was circumvented. 
Further, the brachial approach offers access and arterial 
repair under direct visualization and thus may reduce the 
risk of hematoma and bleeding, and the vascular com- 
dure is performed on an anticoagulated patient [8]. Thus, 
elective stent placement in patients who were treated 
with oral anticoagulation using the brachial approach 
may reduce the required hospitalization time and com- 
plication rate. It must be recognized that vascular com- 
plications with the brachial approach occur in about 1 % 
of procedures in nonanticoagulated patients [9], how- 
ever, and that if bypass surgery were required an in- 
creased need for blood-product transfusion could be an- 
ticipated. 
A limitation of the method is the declining familiarity 
with brachial approach among interventional cardiolo- 
gists. Optimal performance with this technique in anti- 
coagulated patients will require experience in the bra- 
chial approach with sufficient numbers in order to be 
able to perform this delicate procedure efficiently and 
safely. Further, this report is of a single case and the 
safety of this approach will require validation in large 
numbers of patients. 
REFERENCES 
I .  Dotter CT: Transluminally-placed coilspring endoarterial tube 
grafts: Long term patency in canine arteries. Invest Radio1 4:329- 
332, 1969. 
2. Sermys PW, Strauss BH, Beatt KJ, Bertrand ME, Puel J, Rickards 
AF, Meier B, Goy J, Vogt P, Kappenberger L, Sigwart U: Angi- 
ographic follow-up after placement of a self-expanding coronary- 
artery stent. N Engl J Med 324:13-17, 1990. 
3. Schatz RA, Baim DS, Leon M, Ellis SG, Goldberg S, Hinhfeld 
JW, Cleman MW, Cabin HS, Walker C, Stagg J ,  Buchbinder M, 
Teirstein PS, Topol El, Savage M, Perez JA, Curry RC, Whit- 
worth H, Sousa JE, Tio F, Almagor Y, Ponder R. Penn IM, Le- 
onard B, Levine SL, Fish RD, Palmaz JC: Clinical experience with 
the Palmaz-Schatz coronary stent. Circulation 83:148-161, 1991. 
4. Roubin GS, Agrawal S, Dean LS, Baxley WA, Garrhay P, Bajaj 
RK, Gainey P, Cavender JB, Macander P, Cannon A: What are the 
predictors of acute complications following coronary artery stent- 
ing? Single institution experience (abstr). J Am Coll Cardiol 17: 
281A, 1991. 
5 .  Cleman MW, Cabin HS, Leon M, Baim D, Buchbinder M, Schatz 
RA: Major complications associated with intracoronary delivery 
with Palmaz-Schatz stent. J Am Coll Cardiol 17:280-A, 1991. 
6. Dick RJ, Burek KA, Muller DW, Topol El: The incremental costs 
associated with the use of new percutaneous coronary devices. 
Circulation 82:III71, 1990. 
7. Schatz RA: A view of vascular stents. Circulation 79:445-457, 
1989. 
8. Sermys PW, Beatt KJ, van der Giessen WJ: Stenting of coronary 
arteries. Are we the sorcerer’s apprentice? Eur Heart J 10:774- 
782, 1989. 
9. Johnson LW, Lozner EC, Johnson S, Krone R,  Pichard AD, Vetro- 
vec GW, Noto TJ: Coronary arteriography 1984-1987: A report of 
the Registry of the Society for Cardiac Angiography and Interven- 
tions. I. Results and complications. Cath Cardiov Diag 17:5-10, - 
plication rate, especially when an interventional proce- 1989. 
